Douglas Reed M.D., 10% Owner at G1 Therapeutics, Inc. (GTHX), sold 73,692 shares at $51.16 ($3.8M) on 2018-05-21, disclosed to the SEC on 2018-05-23.
Open-market sale of $3.8M GTHX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.06 | 1,595 | $81K | 2.2% |
| 2 | $51.06 | 1,595 | $81K | 2.2% |
| 3 | $51.16 | 29,005 | $1.5M | 39.4% |
| 4 | $51.16 | 29,005 | $1.5M | 39.4% |
| 5 | $52.13 | 26 | $1K | 0.0% |
| 6 | $52.13 | 474 |
| $25K |
| 0.7% |
| 7 | $50.69 | 308 | $16K | 0.4% |
| 8 | $50.86 | 5,592 | $284K | 7.6% |
| 9 | $50.86 | 5,592 | $284K | 7.6% |
| 10 | $50.50 | 26 | $1K | 0.0% |
| 11 | $50.50 | 474 | $24K | 0.6% |
| Total | $51.11 avg | 73,692 | $3.8M | 100% |
| Filing → |
| CLSD | SELL | 2017-01-19 | $512K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $1000K | — | Filing → |
| DRAD | SELL | 2007-08-27 | $92K | — | Filing → |